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Abstract: Objectives: Dehydration in older adults contributes to increased morbidity and mortality 
during hospitalization.  As such, early diagnosis of dehydration may improve patient outcome and 
reduce the burden on healthcare.  This prospective study investigated the diagnostic accuracy of 
routinely used physical signs, and non-invasive markers of hydration in urine and saliva.  Design: 
Prospective diagnostic accuracy study.  Setting: Hospital acute medical care unit and emergency 
department.  Participants: One hundred and thirty older adults (59 males, 71 females, mean (SD) age = 
78 (9) y). Measurements: Participants with any primary diagnosis underwent a hydration assessment 
within 30min of admittance to hospital.  Hydration assessment comprised seven physical signs of 
dehydration (tachycardia (>100bpm), low systolic blood pressure (<100mmHg), dry mucous 
membrane, dry axilla, poor skin turgor, sunken eyes, and long capillary refill time (>2s)), urine color, 
urine specific gravity (USG), saliva flow rate (SFR) and saliva osmolality.  Plasma osmolality (Posm) 
and the blood urea nitrogen to creatinine ratio (BUN:Cr) were assessed as reference standards of 
hydration, with  21% of participants classified with water-loss dehydration (Posm >295mOsm/kg), 
19% classified with water-and-solute-loss dehydration (BUN:Cr >20) and 60% classified as 
euhydrated.  Results: All physical signs showed poor sensitivity (0-44%) for detecting either form of 
dehydration, with only low systolic blood pressure demonstrating potential utility for aiding the 
diagnosis of water-and-solute-loss dehydration (diagnostic OR = 14.7).  Neither urine color, USG, nor 
SFR could discriminate hydration status (area under the receiver operating characteristic curve, 
AUCROC = 0.49-0.57, P>0.05).  In contrast, saliva osmolality demonstrated moderate diagnostic 
accuracy (AUCROC  = 0.76, P<0.001) to distinguish both dehydration types (70% sensitivity, 68% 
specificity, OR =5.0 (95%CI 1.7-15.1) for water-loss dehydration, and 78% sensitivity, 72% specificity, 
OR =8.9 (95%CI 2.5-30.7) for water-and-solute-loss dehydration).   Conclusions: With the exception of 
low systolic blood pressure, which could aid in the specific diagnosis of water-and-solute-loss 
dehydration, physical signs and urine markers show little utility to determine if an elderly patient is 
dehydrated.  Saliva osmolality demonstrated superior diagnostic accuracy compared with physical 
signs and urine markers, and may have utility for the assessment of both water-loss and water-and-
solute-loss dehydration in older individuals. It is particularly noteworthy that saliva osmolality was 
able to detect water-and-solute-loss dehydration, for which a measurement of plasma osmolality 
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To the editor in chief of Journal of the American Medical Directors Association, 
 
Re: Manuscript # JAMDA-D-14-00269, "Is this elderly patient dehydrated? Diagnostic accuracy 
of hydration assessment using physical signs, urine and saliva markers" 
 
Thankyou for allowing us to resubmit the above manuscript to your journal.  We have responded to 
the reviewers comments (see below), with changes in the manuscript highlighted in red text.  We hope 
you feel that these changes have improved the manuscript. 
 









Response to reviewers: 
 
Reviewer #1:  
 
Many thanks for your very insightful and constructive comments.  Below are our responses to your 
comments, and changes within the manuscript are highlighted in red text. We hope you agree that 
these small changes have improved the manuscript. 
 
 
1) Only 42% of screened individuals entered the study, and 31% had sufficient parameters to be 
analyzed.  Although you show numbers in Figure 1, please comment on the large number of 
excluded subjects.  Doesn't this affect the usefulness of the screening in clinical practice? 
 
Thanks.  As you have noted, of those that were screened (n =420), a large number of participants were 
excluded (58%).  However, it should be noted that these were excluded due to ethical reasons of 
conducting the research as stipulated to us by the ethics committee (e.g. patients unable to provide 
consent (incapacity) for the research study (n=98), or that the research should not interfere with 
routine care of the patient and in those who had already began treatment (n = 88)), or because 
participants declined to take part (n = 54). We have now included this information at the start of the 
results sections, along with percentages of those excluded (lines 197-199).  In terms of the application 
of the usefulness in clinical practice, the reasons outlined above do not preclude the usefulness of the 
measures in the current study being used in clinical practice (i.e. in all patients admitted to hospital). 
 
In light of this being a proof of concept study for saliva indices, we did in this instance exclude 
participants who had potential confounding effects on saliva (e.g. oral trauma, recent dental surgery, 
swallowing problems etc), although it should be noted that only 2 participants were excluded for this 
(both had swallowing problems), and in light of your excellent point, we have now added this 
information to the results (lines 198-199,) and Figure 1, and have also now acknowledged in the 
Letter
Click here to download Letter: Clinical hydration indices covering letter response to reviewers 2014.docx
discussion that future studies should investigate whether saliva indices have utility, in patients with 
oral related problems (please see lines 341-344). Thanks. 
 
 
2) "and allowing for an approximate one-third exclusion rate from data analysis (due to  missing 
reference tests, and co-morbidities that preclude the use of the reference standards), a total of 
178 participants were recruited into the study."  It appears that the exclusion rate was higher 
than anticipated?  Please comment. 
 
Please note that the allowance for the one third exclusion rate (for missing reference tests and co-
morbidities that affected the reference standards), was for those who might be excluded from the data 
analysis after they were already recruited into the study (i.e. n = 178 recruited).  The N for which we 
analyzed data was n = 130, with 48 excluded from the data analysis.  The proportion excluded from 
analysis of those recruited (48/178, 27%) is therefore actually lower, not higher than the anticipated 
1/3 exclusion rate. Thanks. 
 
 
3) "participants with a history of renal disease (n = 24), or who were in cardiac failure (n = 1) 
were excluded from data analysis."  Please specify the criteria for renal disease and cardiac 
failure.  What level of renal disease (stage?) or creatinine or other.  For CHF, only "history" or 
other criteria?  As you point out, the presence of renal disease, starvation, malnutrition (among 
others) limit the usefulness of the BUN/Cr ratio.  It would be useful to discuss the level of 
renal disease that you excluded. 
 
Thanks. For this study, we excluded from data analysis, all participants who had any known previous 
history of renal disease (CKD stage 1-5) or if they were in cardiac failure as diagnosed by the 
clinician. We have now clarified this and added this information to the methods section (Line 165).   
In line with comment 1 above, we have also now added a sentence to the discussion where we discuss 
how future studies should investigate the utility of these indices in these relatively small populations 
(lines 318-320). Thanks. 
 
 
4) Please discuss relationship between saliva and blood osmolality.  If the values are generally 
highly correlated, is there any benefit in using saliva rather than blood.  Is it quicker, cheaper, 
easier to use saliva.  Given a paucity of saliva in 25% of subjects, should blood be favored? 
 
This is a very helpful observation and the changes we have made (described below) in response have 
improved the take home message of the manuscript. Many thanks.  
 
As we have addressed in the manuscript (lines 55-61, 169-171 and in Figure 1), plasma osmolality is 
elevated in, and will only detect water-loss dehydration.  In water-and-solute loss dehydration, plasma 
osmolality is either normal or low, and thus has no diagnostic utility for this type of dehydration.  
Given the differential response of plasma osmolality to these two types of dehydration, we feel it 
would be inappropriate to report, or rely on the correlation between saliva and plasma osmolality to 
determine saliva’s utility as a diagnostic method.  In the current study, saliva osmolality was able to 
detect a proportion of patients with water-and-solute dehydration (sensitivity 78%), and is an easier to 
perform and non-invasive so has advantages over blood sampling.   
 
With this in mind, based on your excellent point , as this limitation of plasma (blood) osmolality for 
detecting water-and-solute-loss only dehydration was not as prominent as it should be in the 
manuscript, we have now added a sentence to the end of the abstract (lines 29-31) and to the 
discussion and conclusion where we address this (lines 312-314, 351-352). 
 
We were able to collect a quantity of saliva in 126/130 patients (97%)- reported on lines 210 and 328, 
although as we have stated (lines 213, 327) we only had adequate saliva (at least 25ul) to assess 
osmolality using our osmometer in 75% of samples.  However, we have addressed this limitation in 
the discussion, (line 327-333) where we say that micro osmometers are in development that can assess 




Reviewer #2:  




Is this elderly patient dehydrated? Diagnostic accuracy of hydration assessment using 













, Samuel J. Oliver
1





College of Health and Behavioural Sciences, Bangor University, Bangor, UK. 
2
Geriatric Medicine, Gwynedd Hospital, Betsi Cadwaladr University Health Board, Bangor, 
UK  
 
Corresponding author:  
Prof Neil Walsh, 
College of Health and Behavioural Sciences,  
Bangor University,  
Bangor, 
LL57 2PZ, UK. 
Telephone: +(00) 44 1248 383480 
Email: n.walsh@bangor.ac.uk 
 
Alternative corresponding author: 
Dr Matthew B. Fortes 
College of Health and Behavioural Sciences,  
Bangor University,  
Bangor, 
LL57 2PZ, UK. 
Tel: +(00) 44 1248 388309 
Email: m.fortes@bangor.ac.uk 
 
Keywords: Dehydration, diagnosis, older, hypovolemia, osmolality, clinical  
Running header: Dehydration assessment of older adults. 
 
*Title Page (Containing author details)
1 
 
Is this elderly patient dehydrated? Diagnostic accuracy of hydration assessment using physical signs, 1 
urine and saliva markers 2 
 3 
ABSTRACT  4 
Objectives: Dehydration in older adults contributes to increased morbidity and mortality during 5 
hospitalization.  As such, early diagnosis of dehydration may improve patient outcome and reduce the burden 6 
on healthcare.  This prospective study investigated the diagnostic accuracy of routinely used physical signs, 7 
and non-invasive markers of hydration in urine and saliva.  Design: Prospective diagnostic accuracy study.  8 
Setting: Hospital acute medical care unit and emergency department.  Participants: One hundred and thirty 9 
older adults (59 males, 71 females, mean (SD) age = 78 (9) y). Measurements: Participants with any 10 
primary diagnosis underwent a hydration assessment within 30min of admittance to hospital.  Hydration 11 
assessment comprised seven physical signs of dehydration (tachycardia (>100bpm), low systolic blood 12 
pressure (<100mmHg), dry mucous membrane, dry axilla, poor skin turgor, sunken eyes, and long capillary 13 
refill time (>2s)), urine color, urine specific gravity (USG), saliva flow rate (SFR) and saliva osmolality.  14 
Plasma osmolality (Posm) and the blood urea nitrogen to creatinine ratio (BUN:Cr) were assessed as 15 
reference standards of hydration, with  21% of participants classified with water-loss dehydration (Posm 16 
>295mOsm/kg), 19% classified with water-and-solute-loss dehydration (BUN:Cr >20) and 60% classified as 17 
euhydrated.  Results: All physical signs showed poor sensitivity (0-44%) for detecting either form of 18 
dehydration, with only low systolic blood pressure demonstrating potential utility for aiding the diagnosis of 19 
water-and-solute-loss dehydration (diagnostic OR = 14.7).  Neither urine color, USG, nor SFR could 20 
discriminate hydration status (area under the receiver operating characteristic curve, AUCROC = 0.49-0.57, 21 
P>0.05).  In contrast, saliva osmolality demonstrated moderate diagnostic accuracy (AUCROC  = 0.76, 22 
P<0.001) to distinguish both dehydration types (70% sensitivity, 68% specificity, OR =5.0 (95%CI 1.7-15.1) 23 
for water-loss dehydration, and 78% sensitivity, 72% specificity, OR =8.9 (95%CI 2.5-30.7) for water-and-24 
solute-loss dehydration).   Conclusions: With the exception of low systolic blood pressure, which could aid 25 
in the specific diagnosis of water-and-solute-loss dehydration, physical signs and urine markers show little 26 
utility to determine if an elderly patient is dehydrated.  Saliva osmolality demonstrated superior diagnostic 27 
accuracy compared with physical signs and urine markers, and may have utility for the assessment of both 28 
water-loss and water-and-solute-loss dehydration in older individuals. It is particularly noteworthy that saliva 29 
*Manuscript
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osmolality was able to detect water-and-solute-loss dehydration, for which a measurement of plasma 30 




Dehydration in older adults is a significant clinical problem.  A diagnosis of dehydration is associated with 35 
the presence of co-morbidities, longer hospital stay, additional future hospitalization and higher mortality 36 
rates 
1-5
.  The point-prevalence of dehydration in community-dwelling older adults in the USA was reported 37 
as 17-28% 
6;7
.  In many cases, simple and inexpensive oral rehydration is sufficient to treat dehydration and 38 
halt the progress of more serious fluid-deficit related illnesses such as acute kidney injury.  However, upon 39 
hospitalization, many patients may be denied the correct course of treatment due to physician misdiagnosis 40 
of dehydration 
7
.  Therefore, accurate and early identification of dehydration in older adults admitted to 41 
hospital is vital to alleviate ill-health and the significant economic burden of treating dehydration on 42 
healthcare 
1;2
.  43 
 44 
No single „gold-standard‟ marker of  hydration status exists 
8
, although blood biochemistry including plasma 45 
osmolality, electrolytes and blood urea nitrogen to creatinine ratio (BUN:Cr) represent criterion methods of 46 
identifying dehydration in a clinical setting 
9-12
.  However, blood sample collection is invasive and laboratory 47 
analysis is time-consuming, often delaying the course of treatment by hours.  To aid an initial diagnosis of 48 
dehydration before requesting blood biochemistry confirmation, clinicians may use a variety of simple 49 
screening measures, albeit in a non-systematic way, that may include; presenting signs and symptoms of 50 
dehydration 
11;13;14
, patient history 
13
,  orthostatic blood pressure change 
15
, and/or urinary parameters 
16
.  51 
Nevertheless, these screening methods are often characterized by poor diagnostic performance 
11;17-21
.  To 52 
confound hydration assessment further, the term „dehydration‟ is poorly defined and is used to characterize 53 
many water and solute deficits relating to whole body fluid deficits 
7
.  In order to simplify clinical practice 54 
researchers have suggested the classification of clinical dehydration into two distinct types.  Firstly, water-55 
loss dehydration (also termed hypertonic hypovolemia, or intracellular dehydration), which is hypertonic in 56 
nature and occurs when water loss proportionally exceeds solute loss.  Water loss dehydration is typically 57 
defined as a plasma osmolality ≥295mOsm/kg 
12;22
.  Secondly, water-and-solute-loss dehydration (also 58 
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termed intravascular volume depletion or extracellular dehydration), which may be isotonic or hypotonic due 59 
to equal, or greater proportional loss of solutes than water 
10;12;23
, and typically defined as a BUN:Cr ≥20 in 60 
the absence of hypertonicity 
22
.  To the best of our knowledge, there are few 
18;19
, rigorous studies that have 61 
investigated the diagnostic accuracy of clinical physical signs and/or urine indices to detect dehydration in 62 
hospitalized older adults using a criterion reference method, and none which have simultaneously assessed 63 
the utility of any hydration marker to assess both types of dehydration. 64 
 65 
In a series of studies (in young healthy adults) we have shown that rapid measurements made from non-66 
invasive collection of saliva fluid can be used to identify water-loss dehydration 
24-26
.  For example, 67 
decreases in whole saliva flow rate and increases in whole saliva osmolality were shown to track progressive 68 
modest dehydration (equivalent to 1-3% body mass loss). The utility of these novel saliva markers of 69 
dehydration has not yet been examined in a clinical, older adult population, although encouragingly, the 70 
presence of a dry tongue was identified as the clinical sign most strongly associated with dehydration in an 71 
elderly cohort 
14
.  To this end, the purpose of this prospective study was to determine, and compare, the 72 
diagnostic accuracy of clinical physical signs routinely used in hospital settings 
11;13;14
, along with saliva 73 
(flow rate and osmolality) and urine indices (color and specific gravity) 
27
, to detect static (one-point in time) 74 
water-loss, and water-and-solute-loss dehydration in a hospitalized, older adult cohort using primary 75 






Experimental design and procedures 80 
The study was conducted as a prospective, hospital-based cross-sectional study.  All measures of hydration 81 
status were performed within 30 minutes of admission, with no disruption to routine care in the following 82 
order; examination of physical signs of dehydration, collection of saliva, blood and urine.  For the reference 83 
standards of whole body hydration assessment, a blood sample was collected by the clinical research fellow 84 
or a specialist phlebotomist and analyzed for plasma osmolality (within 15min) and BUN:Cr (within 2h).  85 
For consistency, all physical examinations and assessment of confidential medical information was carried 86 
out by the same clinical research fellow (a junior doctor with five years clinical experience), who was 87 
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blinded to the results of the reference standards and the saliva and urine index test results when conducting 88 
the physical examination.  Saliva and urine samples were collected, and analyzed by an independent research 89 
assistant who had been trained in the handling and assessment of saliva and urine samples by a postdoctoral 90 
researcher, and who was blinded to the physical examination results.  All osmolality analyses were made by 91 
a trained research assistant.  Details of the patients‟ medical condition, history and medication were recorded 92 
retrospectively after the reference and index test results had been established. 93 
 94 
Participants 95 
A convenience sample of adults over 60 years of age admitted consecutively to the acute medical care unit or  96 
emergency department of Gwynedd Hospital, Bangor, UK, with any primary diagnosis and capacity to 97 
consent were enrolled between May and November 2011 during the times the investigators were available 98 
(09:00h – 17:00h, Monday-Friday).  Participant exclusion criteria included: oral trauma or dental surgery 99 
within 14 days, swallowing problems, salivary gland tumors, if they were deemed too unwell by the medical 100 
staff to participate in the study, if they were assessed as not having capacity to consent, or if they had already 101 
begun any form of medical treatment or rehydration therapy (oral or intravenous).  Participant flow through 102 
the study is depicted in Figure 1.  All participants recruited provided fully informed written consent, and the 103 
study adhered to the Declaration of Helsinki and was approved by the North West Wales Research Ethics 104 
Committee (Ref: 11/WA/0023).  105 
 106 
Assessment of hydration status 107 
 108 
Reference standards  109 
Blood sample collection and analysis  110 
Blood samples were collected from an antecubital or dorsal metacarpal vein without venestasis into one 111 
serum separation vacutainer, and one lithium heparin coated vacutainer (Becton Dickinson, Oxford, UK).  112 
Serum blood urea nitrogen and serum creatinine were assessed at the hospital clinical biochemistry 113 
department using an automated biochemistry analyzer (Olympus AU 2700 chemistry immuno analyzer, 114 
Beckman Coulter, USA).  The lithium heparin treated blood was centrifuged immediately upon collection at 115 
1500 g for 10 minutes at 4 °C.  The plasma was aspirated and triplicate measurements of osmolality were 116 
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made immediately using a freezing point depression osmometer (Model 330 MO, Advanced Instruments, 117 
Massachusetts, USA).  Standard control solutions (290 mOsm/kg) were run through the osmometer and 118 
checked daily to ensure acceptable limits of precision (±2 mOsm/kg). The analytical coefficient of variation 119 
for repeated sample plasma osmolality measurements was 0.7% (1.9 mOsm/kg). 120 
 121 
Index tests 122 
Clinical assessment of physical signs of dehydration 123 
The clinical assessment consisted of seven physical signs of dehydration that are routinely used in Gwynedd 124 
Hospital; tachycardia (resting heart rate >100 beats per minute), low resting systolic blood pressure 125 
(<100mmHg), dry mucous membrane (inside of the cheek, dry vs. wet), axillary dryness (assessed by 126 
palpating the armpit, dry vs. moist), poor skin turgor (measured by pinching the skin on the dorsum of the 127 
hand and observing if the tissue fold returned to normal immediately), presence of sunken eyes as assessed 128 
by the clinical research fellow, and long capillary refill time (> 2s, assessed by holding the patients hand at 129 
heart level and blanching the participant's right index finger using moderate pressure and assessing the length 130 
of time for the return of normal color).  Each physical sign was assessed with the participant rested and 131 
seated upright and assessed dichotomously.   132 
 133 
Saliva sample collection and analysis  134 
Unstimulated whole saliva samples were collected using a pre-weighed Versi-sal® collection device (Oasis 135 
Technology, USA) as previously described 
29
.  Participants firstly swallowed in order to empty the mouth of 136 
residual saliva, before saliva was collected by placing the Versi-sal® collection device under the tongue.  137 
Saliva collection was performed with minimal orofacial movements and accurately timed.  After 4 min, the 138 
collection device was inspected for volume of saliva by weighing it immediately (to the nearest milligram) 139 
and subtracting the pre-weight.  If the volume was insufficient for osmolality analysis (< 25µl), the swab was 140 
replaced under the tongue for a further 4 min.  By assuming the density of saliva to be 1.00g/ml, saliva flow 141 
rate (SFR) was calculated by dividing the volume collected by the time of collection 
24
.  Saliva was 142 
recovered from the collection device by centrifugation at 1500 g for 10 min, and assessed immediately in 143 
duplicate for saliva osmolality using a freezing point depression osmometer (Model 330 MO, Advanced 144 
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Instruments, Massachusetts, USA). The analytical coefficient of variation for repeated sample saliva 145 
osmolality measurements was 0.8% (0.9 mOsm/kg). 146 
  147 
Urine sample collection and analysis 148 
A mid-flow urine sample was collected and immediately analyzed for urine color 
27
 and urine specific 149 
gravity (USG) using a handheld refractometer (Atago URC-Osmo refractometer, Japan).  150 
 151 
Sample size calculation and data analysis  152 
The desired sample size for dehydrated participants (n = 20 water-loss only) was calculated using the 153 
following equation: 154 
 155 
n   (1.96)
2
 p(1 - p) 156 




Where p = desired sensitivity (70%) as a proportion, and x = desired confidence interval (20%) as a 159 
proportion 
30
.  Assuming a prevalence of impending water-loss dehydration (plasma osmolality ≥ 160 
295mOsm/kg) of 17% 
7
, and allowing for an approximate one-third exclusion rate from data analysis (due to 161 
missing reference tests, and co-morbidities that preclude the use of the reference standards), a total of 178 162 
participants were recruited into the study.   Medical records for participants were accessed after enrolment, 163 
and due to potential influencing effects on the reference standards assessed in this study, participants with a 164 
history of renal disease (CKD stage 1-5, n = 24), or who were in cardiac failure as diagnosed by a clinician 165 
(n = 1) were excluded from data analysis. Participants were also excluded from data analysis if the reference 166 
tests were not available (n = 11), if they had an abnormally low (<10) BUN:Cr which may be indicative of 167 
renal disease or the syndrome of inappropriate antidiuretic hormone (n = 8), or if they were taking 168 
glucocorticoid medication (n = 4) which affects the validity of the BUN:Cr 
10
.  Based on the reference 169 
standards, participants with a presenting plasma osmolality ≥295mOsm/kg were classified as having 170 
impending water-loss dehydration 
12;22
.  Of the remaining participants, those with a BUN:Cr ≥20 in the 171 
absence of hypertonicity 
22
 were classified as having water-and-solute-loss dehydration, and the remaining 172 




To assess the diagnostic accuracy of saliva and urine indices, and clinical physical signs for assessment of 175 
hydration status, both water-loss, and water-and-solute-loss dehydration groups were separately compared 176 
with the euhydrated control group.  Both dehydration groups were also combined to form a generic 177 
dehydration group for comparison with euhydration.  For all dichotomized clinical physical sign data, the 178 
following were calculated;  area under the receiver operating characteristic curve  (AUCROC) as a measure of 179 
global diagnostic accuracy, sensitivity, specificity, positive and negative likelihood ratios (LR), and the 180 
diagnostic odds ratio (OR) generated by logistical regression. For continuous variable data (urine color, 181 
USG, SFR and saliva osmolality), the degree to which each variable could discriminate between dehydration 182 
and euhydration was assessed using AUCROC.  For variables that could distinguish hydration status, the 183 
single cut-off value that provided the optimal discrimination was identified as the point on the curve with the 184 
largest vertical displacement from the reference line, and sensitivity, specificity, overall diagnostic accuracy, 185 
positive and negative LR, and the diagnostic OR were calculated.  For all diagnostic analyses 95% 186 
confidence intervals were constructed.  To compare AUCROC, a method was adopted that accounts for the 187 
correlation between samples from the same individual 
31
. Group data were analyzed using one-way ANOVA.  188 
Data were analyzed using Microsoft excel (Microsoft, USA), SigmaPlot version 12.0 (Systat Software, Inc. 189 
USA) and SPSS version 20 (IBM Corporation, USA) software.  Significance was accepted as P < 0.05 for all 190 
ANOVA, logistic regression and AUCROC analyses. 191 




Participant characteristics 196 
A total of 420 participants were screened for inclusion, with 242 excluded, largely due to ethical 197 
considerations of conducting the research, or declining to take part (n = 240, 57%), or due to swallowing 198 
problems (n = 2, 1%).  Therefore, 178 participants were enrolled into the study (n = 85 males, n = 93 199 
females) with mean age (SD) 78 (9) y.  After further exclusions for data analysis, data were analyzed for n = 200 
130 participants (n = 59 males, n = 71 females; mean age 78 (9), range 60-101y), of which n = 27 (21%) 201 
were classified as water-loss dehydrated, n = 25 (19%) were classified as water-and-solute-loss dehydrated, 202 
and n = 78 (60%) were classified as euhydrated.  Of the 27 participants in the water-loss only dehydration 203 
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group, 10 also had an elevated BUN:Cr (≥20).  There were no differences between the groups for age (Table 204 
1).  By design, participants with water-loss dehydration had elevated plasma osmolality, and participants 205 
with water-and-solute-loss dehydration had elevated BUN:Cr  compared with euhydrated control (Table 1). 206 
***Insert Table 1 about here*** 207 
 208 
Feasibility of collecting index tests 209 
All clinical physical sign assessments were conducted in all 130 participants.  Saliva was collected in all but 210 
four participants (1 water-loss dehydrated, 2 water-and-solute-loss dehydrated, and 1 euhydrated control).  211 
For these four participants SFR was recorded as zero, and SFR data was therefore analyzed for n = 130.  212 
There was adequate saliva (> 25µl) to assess saliva osmolality in 98 participants (75%).  In comparison urine 213 
samples could not be collected in 45 participants, who were unable to urinate within 30 min of the blood 214 
collection. One participant provided a urine sample containing blood, confounding interpretation.  Urine 215 
color and specific gravity were therefore analyzed in 84 participants (65%). 216 
 217 
Diagnostic accuracy of clinical physical signs 218 
Diagnostic data for all seven clinical physical signs for both types of dehydration are shown in Table 2 and 219 
Figure 2.  No clinical physical sign in isolation could discriminate between euhydration and either form of 220 
dehydration (AUCROC range 0.44-0.57).  Individually, all clinical physical signs performed poorly in terms of 221 
detecting dehydration with sensitivity ranging from 0–44%.  They did however generally perform better at 222 
detecting euhydration, with specificity ranging from 60-99%.  For detecting water-and-solute-loss 223 
dehydration, a low resting systolic blood pressure (<100mmHg) demonstrated high diagnostic odds and 224 
likelihood ratios (14.7 (95% CI 1.6-138.3) and 12.5 (95%CI 1.5-107 respectively)), suggesting potential 225 
utility in aiding the diagnosis of this specific type of dehydration. 226 
***Insert Table 2 about here*** 227 
 228 
Diagnostic accuracy of urine and saliva indices 229 
There were no differences between any of the three groups for urine color, USG or SFR (Table 1).  230 
Furthermore, when assessed using ROC analyses, neither urine color, USG or SFR were able to discriminate 231 
between dehydration and euhydration (AUCROC range 0.49-0.57, all P > 0.05, Table 3).  Saliva osmolality 232 
9 
 
was greater in participants with both forms of dehydration than euhydrated control (P < 0.001, Table 1), but 233 
more importantly, was able to distinguish both types of dehydration separately from euhydration (AUCROC = 234 
0.76, P < 0.01 for both types of dehydration individually and combined, Table 3).  Based on the ROC 235 
analysis, the saliva osmolality cut-off that provided the optimum balance between sensitivity and specificity 236 
was calculated as: 95, 97, and 94 mOsm/kg for water-loss only, water-and-solute-loss only, and both forms 237 
of dehydration combined, respectively.  The diagnostic accuracy of saliva osmolality to detect all 238 
dehydration types is displayed in Table 4.  Saliva osmolality was able to identify water-loss dehydration, 239 
water-and-solute-loss dehydration, and both forms of dehydration combined with a sensitivity of 70, 78 and 240 
76%, and specificity of 68, 72, and 68%, respectively.  Importantly, when AUCROC curves were compared, 241 
the ability of saliva osmolality to discriminate hydration status was superior (P < 0.05) to all clinical physical 242 
signs and urine indices for both types of dehydration in older adults (Figure 2). 243 
***Insert Table 3 and Table 4 about here***    ***Insert Figure 2 about here*** 244 
 245 
DISCUSSION 246 
Dehydration in older adults is a leading cause of hospitalizations, contributing to increased morbidity and 247 
mortality during clinical care, and poorer functional status of the individual 
1-5;32
.  As such, early 248 
identification of hydration status is paramount to prevent the development of further co-morbidities, and to 249 
reduce the burden on healthcare 
1;2
.  This prospective study sought to investigate the diagnostic accuracy of 250 
routinely used clinical physical signs and urine indices, and novel, simple, non-invasive saliva indices.  The 251 
main finding was that currently used clinical physical signs were not able to discriminate between 252 
dehydration and euhydration, and thus provide little help to the physician making an initial hydration 253 
assessment.  The exception was a low systolic blood pressure which could aid in the specific diagnosis of 254 
water-and-solute-loss dehydration.  Whilst showing promise in young healthy cohorts 
27
, urine analysis 255 
demonstrated no utility in identifying dehydration in an older adult cohort admitted to hospital.  However, 256 
the novel finding from the study was that saliva osmolality could discriminate between dehydration and 257 
euhydration, and importantly, was sensitive to both water-loss, and water-and-solute-loss forms of 258 
dehydration, demonstrating superior diagnostic accuracy than urinary parameters and currently used clinical 259 
physical signs.  Saliva collection is non-invasive, and easy to collect, and therefore, may have practical 260 




Despite a relative paucity of clear supporting evidence, clinicians may rely on an array of simple physical 263 
screening tests to aid the hydration assessment of patients admitted to hospital.  Whilst showing some 264 
clinical promise in young children 
33;34
, clinical physical signs often demonstrate poor diagnostic 265 
performance when applied to older adults, likely due to; a loss of skin elasticity with advancing age affecting 266 
skin turgor, smoking and cold environmental temperatures causing peripheral vasoconstriction which may 267 
result in false positives for capillary refill time, and anticholinergic medications and a reliance on mouth 268 
breathing in the elderly which can result in a dry oral mucosa 
11;17;35
.  Findings from previous studies 269 
investigating the utility of clinical physical signs should also be viewed with caution where they have 270 
adopted a  non-criterion reference standard, e.g. difference in weight gain after rehydration 
13
, urinary 271 
measures 
16
, or relied on a clinicians overall diagnosis 
14
 as opposed to a more, objective biochemical 272 
criterion measure such as plasma osmolality 
7;10-12;17;22;36
. Furthermore, previous studies have been limited by 273 
failing to characterize the diagnostic accuracy of clinical physical signs in assessing both forms of 274 





A particular strength of the current study was that both forms of dehydration were characterized 278 
simultaneously using valid biochemical assessments as reference standards, including the preferred direct 279 
measurement of plasma osmolality as opposed to calculated osmolality 
12;37
.  We observed that no clinical 280 
physical sign could discriminate between either type of dehydration and euhydration when assessed using 281 
AUCROC, and thus, should not be used in isolation to diagnose hydration status in older adults admitted to 282 
hospital.  However, although not sensitive (16%), a low (<100mmHg) sitting systolic blood pressure, may 283 
aid the physician in making a diagnosis of water-and-solute-loss dehydration owing to its very high 284 
specificity (i.e. low false positive rate), high diagnostic odds ratio (OR =14.7), and high positive likelihood 285 
ratio (OR =12.5).  This finding is in line with the well-known effects of a loss of extracellular fluid 286 
(intravascular volume depletion) on blood pressure responses.  Although researchers have previously focused 287 
on orthostatic blood pressure responses to assess hydration 
13;15
, altering posture may be impractical in a 288 
clinical setting, particularly in bed-ridden patients.  Therefore, a sitting blood pressure assessment may have 289 




Urinary markers have been reported as valid methods to assess acute changes in hydration status in young 292 
healthy people 
27
.  In the current study, neither USG nor urine color were able to discriminate between 293 
dehydration and euhydration.  This is likely due in part, to the decreased renal function that is characteristic 294 
of older age, and to a potential confounding effect on urine of the many types of medications that an older 295 
adult cohort are likely to be prescribed.  In support, previous studies have also shown that urine indices are 296 
poor markers of hydration status in elderly patients 
13;19
, in critically ill patients 
20
 and in young children with 297 
gastroenteritis 
38
.  Urine collection is not always possible when required, and was only able to be collected in 298 
65% of participants in the current study, and in only 79% of elderly patients in a recent clinical study 
13
.  299 
Taken together, we do not recommend the use of USG or urine color as screening tools for dehydration in 300 
older adults. 301 
 302 
To the best of our knowledge, this is the first study that has investigated the diagnostic accuracy of saliva 303 
indices to assess dehydration in older adults admitted to hospital.  Saliva sample collection is simple and 304 
non-invasive and has previously been shown to track modest water-loss dehydration in young healthy males 305 
24-26
.  Saliva flow rate was not associated with either form of dehydration, but the novel finding of the current 306 
study was that saliva osmolality was able to detect both forms of dehydration with sensitivity >70% and 307 
diagnostic OR >5.  Although a sensitivity to detect dehydration of 72-78% may only be described as “fair to 308 
moderate” 
39
, it is important to stress that any novel diagnostic marker should be compared against what is 309 
currently used in clinical practice, and in the case of the present study, a high saliva osmolality 310 
(>94mOsm/kg) was able to detect more cases of both types of dehydration than any single clinical physical 311 
sign or urinary marker without compromising specificity (Figure 2).  It is also worth re-iterating that saliva 312 
osmolality was able to detect water-and-solute-loss dehydration, for which a measurement of plasma 313 
osmolality would have no diagnostic utility.  Furthermore, the cohort in the current study reflects a 314 
representative, older adult clinical population, admitted with any primary diagnosis, and we did not remove 315 
participants taking medications (except for 4 patients taking glucocorticoid medications).  Thus, the fact that 316 
a single marker is able to achieve a sensitivity > 70% for both types of dehydration at one-point in time 317 
regardless of medication is promising.  It remains unknown whether saliva osmolality can also identify both 318 
types of dehydration in the relatively small proportion of patients in this study taking glucocorticoid 319 
12 
 
medication, in patients with heart failure, and in those with various stages of kidney disease.  Finally, since 320 
we set our reference standard cut-off at the lower end of the dehydration continuum to reflect impending, or 321 
pre-clinical dehydration 
10;12;22
, the measurement of saliva osmolality may have practical utility in identifying 322 
those individuals with modest dehydration, so that further biochemistry analysis can confirm the presence of, 323 
and type of dehydration, in order that specific, tailored rehydration is commenced to prevent the patient 324 
developing more severe dehydration along with its associated co-morbidities and poorer outcome.  325 
 326 
There are a few limitations of saliva that we must acknowledge.  Firstly, in the current study, the requirement 327 
of 25 µl of saliva sample for analysis meant that only 75% of the samples could be analyzed (although a 328 
measurable quantity of saliva was collected from 97% of participants compared with only 65% of 329 
participants able to provide a urine sample).  However, point of care devices that utilize nano-technology for 330 
the assessment of saliva osmolality are under development 
40;41
.  For example, the osmolarity of tears can 331 
now be assessed using the principle of impedance on as little as 50nl 
42;43
.  Thus, this limitation should not be 332 
seen to detract from the future application of saliva osmolality to assess hydration status in clinical care.  333 
Secondly, with saliva sampling in a clinical population, there may be a potential confounding effect of 334 
anything which can affect saliva flow rate, e.g. anticholinergic medications, or recent food/fluid consumption 335 
44;45
.  This is potentially important since a decrease in saliva flow explained in part, the increase in saliva 336 
osmolality observed during acute dehydration in young healthy males 
24-26
.  However, we observed only a 337 
small association between saliva flow rate and osmolality (r = -0.40), suggesting that in the current study, 338 
saliva osmolality was largely independent of saliva flow rate.  The physiological mechanisms responsible for 339 
an increase in saliva osmolality during dehydration are unclear, but may be due to an increase in water 340 
absorption in the saliva gland and/or neural factors 
24-26
.  Finally, although we excluded only 2 participants 341 
with swallowing problems, further research should investigate the diagnostic utility of saliva indices in 342 
patients with this, and other oral-related problems (e.g. oral trauma, recent dental surgery, salivary gland 343 
tumors etc). 344 
 345 
CONCLUSIONS 346 
In conclusion, with the exception of low systolic blood pressure, which could aid in the specific diagnosis of 347 
water-and-solute-loss dehydration, physical signs and urine markers show little utility to determine if an 348 
13 
 
elderly patient is dehydrated.  Saliva osmolality demonstrated superior diagnostic accuracy compared with 349 
physical signs and urine markers for the assessment of both water-loss and water-and-solute-loss 350 
dehydration.  It is particularly noteworthy that saliva osmolality was able to detect water-and-solute-loss 351 
dehydration, for which a measurement of plasma osmolality would have no diagnostic utility. The 352 
measurement of saliva osmolality has potential utility as a screening method to aid the diagnosis of 353 
impending dehydration in older adults.  354 
 355 
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FIGURE LEGENDS: 472 
 473 
Figure 1. Participant flow through the study. BUN, blood urea nitrogen. 474 
 475 
 476 
Figure 2.  ROC curve comparison between clinical physical signs, saliva and urine indices for the 477 
assessment of dehydration.  Data are shown for both forms of dehydration combined (A), water-loss 478 
dehydration only (B) and water-and-solute-loss dehydration (C).  The cut-off that provides the optimum 479 
discrimination between sensitivity (true positive rate) and specificity (false positive rate) is plotted. BP, low 480 
systolic blood pressure; SE, sunken eyes; CR, capillary refill time; Tc, Tachycardia; AD, axillary dryness, 481 
ST, skin turgor, DM, dry mucous membrane; Sosm, saliva osmolality; SF, saliva flow rate; UrC, urine color; 482 
USG, urine specific gravity.  Vertical error lines represent sensitivity 95% CI, horizontal error lines represent 483 
specificity 95% CI.   484 
 485 
Table 1. Group data for age, blood reference tests and urine and saliva index tests of hydration. 
    
Water-loss only 
dehydrated             
(n = 27) 
Water-and-solute-loss 
only dehydrated                     
(n = 25) 
Euhydrated 
controls                    
(n = 78) 




Age (Yr) 78.3 (9.6) 80.1 (9.6) 76.3 (7.7) 0.14 
Reference tests 
Plasma osmolality (mOsm/kg) 299 (6)† 283 (6) 283 (9) <0.001 
BUN:Cr 18.8 (5.5) 24.3 (4.7)‡ 15.7 (2.6) <0.001 
Index tests 
Urine specific gravity 1.017 (0.006) 1.016 (0.007) 1.016 (0.006) 0.77 
Urine color 4.1 (1.6) 3.9 (1.8) 3.9 (1.7) 0.87 
Saliva flow rate (µl/min) 56 (55) 86 (183) 77 (90) 0.57 
Saliva osmolality (mOsm/kg) 136 (58)* 140 (66)* 92 (45) <0.001 
Values represent mean (standard deviation). BUN:Cr; blood urea nitrogen to creatinine ratio. 
† Significantly greater than water-and-solute-loss only dehydrated and euhydrated control groups (P < 0.001). 
‡ Significantly greater than water-loss only dehydrated and euhydrated control groups (P < 0.001). 
* Significantly greater than euhydrated control group (P < 0.01). 
 
Table 1
Table 2. Diagnostic accuracy of clinical signs to determine both forms of dehydration in combination, and separately (water-loss only, and water-and-solute 




Water-loss only dehydration 
 
Water-and-solute-loss only dehydration 























               
Low systolic BP             
(< 100 mmHg) 
0.53 6.0 0.9 6.4 
 
0.49 N/A 1 N/A 
 
0.57 12.5 0.9 14.7* 
(0.43-0.64) (0.7-54.2) (0.8-1.0) (0.7-59.1) 
 
(0.37-0.62) N/A (1) N/A 
 
(0.44-0.71) (1.5-107.6) (0.7-1.0) (1.6-138.3) 
Tachycardia              
(HR > 100 bpm) 
0.50 1.0 1.0 1.0 
 
0.44 0.5 1.2 0.4 
 
0.56 1.6 0.8 1.9 
(0.40-0.60) (0.5-1.9) (0.8-1.2) (0.4-2.3) 
 
(0.32-0.56) (0.2-1.5) (1.0-1.4) (0.1-1.5) 
 
(0.43-0.70) (0.8-3.0) (0.6-1.1) (0.7-5.0) 
Dry mucous 
membrane 
0.51 1.1 1.0 1.1 
 
0.51 1.0 1.0 1.0 
 
0.52 1.1 0.9 1.2 
(0.41-0.62) (0.7-1.6) (0.7-1.3) (0.5-2.3) 
 
(0.38-0.63) (0.6-1.7) (0.7-1.4) (0.4-2.5) 
 
(0.39-0.65) (0.7-1.9) (0.6-1.4) (0.5-3.0) 
Axillary dryness 
0.54 1.3 0.9 1.4 
 
0.53 1.2 0.9 1.3 
 
0.56 1.4 0.8 1.7 
(0.44-0.64) (0.8-2.0) (0.7-1.2) (0.7-3.0) 
 
(0.40-0.65) (0.6-2.1) (0.7-1.3) (0.5-3.1) 
 
(0.43-0.70) (0.8-2.4) (0.6-1.2) (0.7-4.2) 
Poor skin turgor 
0.55 1.3 0.9 1.5 
 
0.53 1.2 0.9 1.3 
 
0.57 1.4 0.8 1.7 
(0.45-0.65) (0.8-2.0) (0.6-1.1) (0.7-3.1) 
 
(0.40-0.66) (0.7-2.0) (0.6-1.3) (0.5-3.2) 
 
(0.44-0.70) (0.8-2.3) (0.5-1.2) (0.7-4.3) 
Sunken eyes 
0.51 1.2 1.0 1.2 
 
0.43 0.6 1.1 0.5 
 
0.56 1.9 0.9 2.2 
(0.41-0.62) (0.5-2.8) (0.8-1.1) (0.5-3.4) 
 
(0.35-0.60) (0.1-2.5) (0.9-1.2) (0.1-2.7) 
 
(0.42-0.69) (0.8-4.6) (0.7-1.1) (0.7-6.7) 
Capillary refill         
> 2 S 
0.50 1.0 1.0 1.0 
 
0.52 1.2 1.0 1.2 
 
0.48 0.8 1.0 0.8 
(0.40-0.60) (0.5-2.0) (0.8-1.2) (0.4-2.4)   (0.39-0.64) (0.5-2.7) (0.8-1.2) (0.5-3.5)   (0.36-0.61) (0.3-2.3) (0.9-1.3) (0.2-2.7) 
AURROC, area under the receiver operating characteristic curve; LR, likelihood ratio; OR, odds ratio; BP, blood pressure; HR, heart rate; * P < 0.05 
significantly associated with hydration status by logistic regression analysis. N/A, not assessed as sensitivity was 0%. 
 
Table 2
Table 3. Receiver operating characteristic (ROC) area under the curve (AUC) analysis 
for urine and saliva indices for the detection of dehydration in older adults (>60yr).  
   
ROC analysis 
      AUC P value 
All dehydration  
















Saliva flow rate 
 
0.56 0.25 







   
(0.66-0.86) 
 
Water loss only dehydration 
















Saliva flow rate 
 
0.55 0.46 







   
(0.66-0.87) 
 
Water and solute loss dehydration 
















Saliva flow rate 
 
0.57 0.28 







      (0.62-0.89)   
Values in parentheses represent 95% confidence intervals. USG, urine specific gravity. 
 
Table 3
Table 4. Diagnostic accuracy of saliva osmolality to determine both forms of 
dehydration in combination, and separately  (water-loss only, and water-and-










Both forms of 
dehydration combined 
71% 2.4 0.4 6.9 
(63-80%) (1.6-3.6) (0.2-0.6) (2.8-17.5) 
Water-loss 
dehydration 
69% 2.2 0.4 5.0 
(59-79%) (1.4-3.5) (0.2-0.9) (1.7-15.1) 
Water-and-solute-loss 
dehydration 
73% 2.8 0.3 8.9 
(63-83%) (1.7-4.4) (0.1-0.8) (2.5-30.7) 
Values in parentheses represent 95% Confidence intervals.  LR, likelihood 
ratio; OR, odds ratio. 
 
Table 4
Assessed for eligibility N = 420
Excluded, N = 242
Not eligible (too unwell to participate, 
assessed as incapacity to consent), N = 98
Declined, N = 54
Swallowing problems , N = 2
Other (e.g. treatment already begun, 
wearing oxygen mask) N = 88
Agreed to participate and signed informed
consent, N = 178
Excluded from analysis ( N = 48):
Missing reference standard, N = 11
Missing Plasma osmolality, N = 1
Missing BUN:Creatinine ratio, N = 10
Renal disease or cardiac failure, N = 25
Renal disease, N = 24
Cardiac failure, N = 1
Abnormally low BUN:creatinine ratio (<10), N = 8
Prescribed glucocorticoids which can interfere
with BUN:creatinine ratio, N = 4
Assessed for hydration status based on
reference standards (plasma osmolality
and BUN:creatinine ratio), N = 130
Water loss dehydration group
Plasma osmolality ³ 295 mOsm/kg
Data analyzed for N = 27 (21%)
Water-and-solute-loss dehydration group
BUN:creatinine ratio ³ 20, and normal plasma osmolality
Data analyzed for N = 25 (19%)
Euhydration group
Normal plasma osmolality and
BUN:creatinine ratio
Data analyzed for N = 78 (60%)
All forms of dehydration, N = 52
Figure 1











































































































Manuscript # JAMDA-D-14-00269, "Is this elderly patient dehydrated? Diagnostic accuracy of 
hydration assessment using physical signs, urine and saliva markers" – Response to reviewers 
 
Reviewer #1:  
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comments, and changes within the manuscript are highlighted in red text. We hope you agree that 
these small changes have improved the manuscript. 
 
 
1) Only 42% of screened individuals entered the study, and 31% had sufficient parameters to 
be analyzed.  Although you show numbers in Figure 1, please comment on the large number 
of excluded subjects.  Doesn't this affect the usefulness of the screening in clinical practice? 
 
Thanks.  As you have noted, of those that were screened (n =420), a large number of participants 
were excluded (58%).  However, it should be noted that these were excluded due to ethical reasons 
of conducting the research as stipulated to us by the ethics committee (e.g. patients unable to 
provide consent (incapacity) for the research study (n=98), or that the research should not interfere 
with routine care of the patient and in those who had already began treatment (n = 88)), or because 
participants declined to take part (n = 54). We have now included this information at the start of the 
results sections, along with percentages of those excluded (lines 197-199).  In terms of the 
application of the usefulness in clinical practice, the reasons outlined above do not preclude the 
usefulness of the measures in the current study being used in clinical practice (i.e. in all patients 
admitted to hospital). 
 
In light of this being a proof of concept study for saliva indices, we did in this instance exclude 
participants who had potential confounding effects on saliva (e.g. oral trauma, recent dental surgery, 
swallowing problems etc), although it should be noted that only 2 participants were excluded for this 
(both had swallowing problems), and in light of your excellent point, we have now added this 
information to the results (lines 198-199,) and Figure 1, and have also now acknowledged in the 
discussion that future studies should investigate whether saliva indices have utility, in patients with 
oral related problems (please see lines 341-344). Thanks. 
 
 
2) "and allowing for an approximate one-third exclusion rate from data analysis (due to  
missing reference tests, and co-morbidities that preclude the use of the reference 
standards), a total of 178 participants were recruited into the study."  It appears that the 
exclusion rate was higher than anticipated?  Please comment. 
 
Please note that the allowance for the one third exclusion rate (for missing reference tests and co-
morbidities that affected the reference standards), was for those who might be excluded from the 
data analysis after they were already recruited into the study (i.e. n = 178 recruited).  The N for 
which we analyzed data was n = 130, with 48 excluded from the data analysis.  The proportion 
excluded from analysis of those recruited (48/178, 27%) is therefore actually lower, not higher than 
the anticipated 1/3 exclusion rate. Thanks. 
 
 
3) "participants with a history of renal disease (n = 24), or who were in cardiac failure (n = 1) 
were excluded from data analysis."  Please specify the criteria for renal disease and cardiac 
failure.  What level of renal disease (stage?) or creatinine or other.  For CHF, only "history" 
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or other criteria?  As you point out, the presence of renal disease, starvation, malnutrition 
(among others) limit the usefulness of the BUN/Cr ratio.  It would be useful to discuss the 
level of renal disease that you excluded. 
 
Thanks. For this study, we excluded from data analysis, all participants who had any known previous 
history of renal disease (CKD stage 1-5) or if they were in cardiac failure as diagnosed by the 
clinician. We have now clarified this and added this information to the methods section (Line 165).   
In line with comment 1 above, we have also now added a sentence to the discussion where we 
discuss how future studies should investigate the utility of these indices in these relatively small 
populations (lines 318-320). Thanks. 
 
 
4) Please discuss relationship between saliva and blood osmolality.  If the values are generally 
highly correlated, is there any benefit in using saliva rather than blood.  Is it quicker, 
cheaper, easier to use saliva.  Given a paucity of saliva in 25% of subjects, should blood be 
favored? 
 
This is a very helpful observation and the changes we have made (described below) in response have 
improved the take home message of the manuscript. Many thanks.  
 
As we have addressed in the manuscript (lines 55-61, 169-171 and in Figure 1), plasma osmolality is 
elevated in, and will only detect water-loss dehydration.  In water-and-solute loss dehydration, 
plasma osmolality is either normal or low, and thus has no diagnostic utility for this type of 
dehydration.  Given the differential response of plasma osmolality to these two types of 
dehydration, we feel it would be inappropriate to report, or rely on the correlation between saliva 
and plasma osmolality to determine saliva’s utility as a diagnostic method.  In the current study, 
saliva osmolality was able to detect a proportion of patients with water-and-solute dehydration 
(sensitivity 78%), and is an easier to perform and non-invasive so has advantages over blood 
sampling.   
 
With this in mind, based on your excellent point , as this limitation of plasma (blood) osmolality for 
detecting water-and-solute-loss only dehydration was not as prominent as it should be in the 
manuscript, we have now added a sentence to the end of the abstract (lines 29-31) and to the 
discussion and conclusion where we address this (lines 312-314, 351-352). 
 
We were able to collect a quantity of saliva in 126/130 patients (97%)- reported on lines 210 and 
328, although as we have stated (lines 213, 327) we only had adequate saliva (at least 25ul) to assess 
osmolality using our osmometer in 75% of samples.  However, we have addressed this limitation in 
the discussion, (line 327-333) where we say that micro osmometers are in development that can 
assess osmolality on nano-gram quantities. We hope you feel that this is adequately addressed in 
the manuscript. Thanks. 
 
 
Reviewer #2:  
Many thanks for reviewing our manuscript. 
 
